Body Mass Index and Polygenic Risk for Alzheimer's Disease Predict Conversion to Alzheimer's Disease. (21st April 2021)

• Record Type: Journal Article
• Authors: Moody, Jena N; Valerio, Kate E; Hasselbach, Alexander N; Prieto, Sarah; Logue, Mark W; Hayes, Scott M; Hayes, Jasmeet P
• Editors: Le Couteur, David
• Is Part Of: Journals of gerontology. Volume 76:Number 8(2021)
• Page Start: 1415
• Page End: 1422
• Publication Date: 2021-04-21
• Subjects: Genetics -- Health factors -- Mild cognitive impairment -- Neurodegenerative disease -- Sex differences; Geriatrics -- Periodicals; Gerontology -- Periodicals; 618.97
• DOI: 10.1093/gerona/glab117
• Languages: English
• ISSNs: 1079-5006

Abstract

Abstract: Body mass index (BMI) is a risk factor for Alzheimer's disease (AD) although the relationship is complex. Obesity in midlife is associated with increased risk for AD, whereas evidence supports both higher and lower BMI increasing risk for AD in late life. This study examined the influence of individual differences in genetic risk for AD to further clarify the relationship between late-life BMI and conversion to AD. Participants included 52 individuals diagnosed as having mild cognitive impairment (MCI) at baseline who converted to AD within 24 months and 52 matched MCI participants from the Alzheimer's Disease Neuroimaging Initiative (ADNI) cohort. BMI was measured at baseline. Genetic risk for AD was assessed via genome-wide polygenic risk scores. Conditional logistic regression models were run to determine if BMI and polygenic risk predicted conversion to AD. Results showed an interaction between BMI and genetic risk, such that individuals with lower BMI and higher polygenic risk were more likely to convert to AD relative to individuals with higher BMI. These results remained significant after adjusting for cerebrospinal fluid biomarkers of AD. Exploratory sex-stratified analyses revealed this relationship only remained significant in males. These results show that higher genetic risk in the context of lower BMI predicts conversion to AD in the next 24 months, particularly among males. These findings suggest that genetic risk for AD in the context of lower BMI may serve as a prodromal risk factor for future conversion to AD.